Your partner for innovative clinical trial solutions
We are an oncology clinical contract research organization (CRO) committed to providing the guidance, attention, and flexibility needed to advance oncology therapies for the benefit of patients.
We can help you translate your novel oncology therapy from the bench to the clinic
Navigating complex clinical and regulatory pathways can be challenging. With our guidance, emerging biopharma and biotech companies can:
Full support of outsourced clinical trials
LumaBridge is an oncology-focused CRO providing assistance across the entire continuum of clinical development.
Under the leadership of founder and CEO Dr. George Peoples, LumaBridge is advancing novel immunotherapies in the fight against cancer. As part of our comprehensive CRO services, we offer consultation on trial design and clinical development strategy, as well as assistance for CPRIT applicants.
Project and vendor management
Clinical data management
Medical writing and biostatistics
Medical monitoring and pharmacovigilance
Rely on an oncology CRO that can design and execute a study with efficiency, flexibility, and urgency
We provide the innovative trial solutions, strategic partnership, and attention necessary to bring life-changing therapies to patients.
Why sponsors rely on LumaBridge
We act as a strategic development partner, combining academic, scientific, and commercial perspectives to deliver oncology CRO services that exceed expectations—and ultimately advance novel immunotherapies to benefit patients.
We are dedicated to creating innovative clinical trial solutions
As academic research experts and commercial strategists, we understand what our partners are facing. Founder and CEO Dr. George Peoples is a pioneer in immuno-oncology with more than 25 years in IO research and surgical oncology. His work has laid the foundation for many modern therapies.